SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-036625
Filing Date
2022-03-22
Accepted
2022-03-22 17:09:15
Documents
14
Period of Report
2022-03-22
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210113d1_8k.htm   iXBRL 8-K 48840
2 EXHIBIT 3.1 tm2210113d1_ex3-1.htm EX-3.1 9549
3 EXHIBIT 3.2 tm2210113d1_ex3-2.htm EX-3.2 42273
  Complete submission text file 0001104659-22-036625.txt   291794

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20220322.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20220322_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20220322_pre.xml EX-101.PRE 22587
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210113d1_8k_htm.xml XML 3287
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 22760586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences